LIGAND PHARMACEUTICALS INCORPORATED Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2025-02-28: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market.
- 2024-02-29: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market.
- 2023-02-28: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market.
- 2022-02-28: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2025-02-28 | 10-K | Stock registered under Section 12(b) | Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market |
| 2024-02-29 | 10-K | Stock registered under Section 12(b) | Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market |
| 2023-02-28 | 10-K | Stock registered under Section 12(b) | Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market |
| 2022-02-28 | 10-K | Stock registered under Section 12(b) | Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market |
| 2021-02-24 | 10-K | Stock registered under Section 12(b) | Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market |
| 2020-02-27 | 10-K | Stock registered under Section 12(b) | Common Stock, par value $.001 per share · LGND · The Nasdaq Global Market |
| 2016-02-26 | 10-K | Shares outstanding as of 2016-02-17 | 20,773,073 |
| 2016-02-26 | 10-K | Public float as of 2015-06-30 | $1.90B |